Optimizing the Management of ED
Intracerebral Hemorrhage Patients

Tuesday, September 27, 2005
Washington, D.C.

ferne_cme

Symposium Introduction

Edward P. Sloan, MD, MPH, FACEP

 

ICH Pathophysiology: What You Don't Know

Marc Dorfman, MD, FACEP, MACP
EM Residency Program Director
Department of Emergency Medicine
Ressurrection Medical Center
Chicago, IL

 

10 Things You Must Know When Treating ED ICH Patients

Edward C. Jauch, MD, MS, FACEP
Assistant Professor
Department of Emergency Medicine
University of Cinicnnati
Cincinnati, OH

 

Head CT Interpretation in the ED: The Complete Primer

Brian A. Stettler, MD
Assistant Professor Clin Geo
Department of Emergency Medicine
University of Cincinnati
Cincinnati, OH

 

MRI/MRA in Diagnosis ED Acute Stroke and ICH Patients

Edward P. Sloan, MD, MPH, FACEP
Professor
Department of Emergency Medicine
University of Illinois College of Medicine
Chicago, IL

 

ICH Journal Club: Important Articles from 2005!

Edward P. Sloan, MD, MPH, FACEP
Professor
Department of Emergency Medicine
University of Illinois College of Medicine
Chicago, IL

 

Treating ICH in the Anti-coagulated Patient

Edward P. Sloan, MD, MPH, FACEP
Professor
Department of Emergency Medicine
University of Illinois College of Medicine
Chicago, IL

Background

ICH is a devastating disease that often causes patients to present to the Emergency Department in critical condition, with unstable vital signs, altered mental status, and in need of urgent airway management. It is incumbent on the emergency physician to quickly stabilize these patients, diagnose their condition, and decide on urgent treatment strategies that will optimize the chances for a good outcome. This symposium is designed to make it possible for the emergency physician to have the knowledge and skills necessary to consistently make this happen for ED patients.


Learning Objectives
Upon program completion, participants should be able to:

 

This symposium is supported in part through an unrestricted educational grant from Novo Nordisk Pharmaceuticals, Inc.